MedTrace Logo

Polyunsaturated Fatty Acids in Child Nutrition

NCT01487889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2014-11-06

No results posted yet for this study

Summary

Primary objective of this study is to examine the effects of 2 different approaches of dietary strategies to optimise fatty acid composition in complementary food on infant's fatty acid status and its consequences on cognitive and visual development.

Subjects are randomly assigned to one of three groups:

* Rapeseed oil (high in n-3 PUFA and small n-6:n-3 ratio to support endogenous n- 3 LC-PUFA metabolism)
* Fatty fish (preformed n-3 LC-PUFA, especially DHA)
* Corn oil (as control group, high in n-6 PUFA, common in complementary food).

The intervention starts with the beginning of complementary feeding as generally recommended between 4 to 6 months of age and ends at the age of 10 months. For this period of time subjects of all groups receive commercial vegetable-potato-meat-meals as part of complementary food which only differs in the fatty acid composition.

Conditions

  • Fatty Acid Status

Interventions

OTHER

Fatty acid composition of complementary food

Groups receive commercial vegetable-potato-meat-meals as part of complementary food which differs in the fatty acid composition

Sponsors & Collaborators

  • Dr. von Hauner Children's Hospital, Germany

    collaborator UNKNOWN

  • University of Potsdam

    collaborator OTHER

  • Pediatric Clinic Dortmund, Germany

    collaborator UNKNOWN

  • Research Institute of Child Nutrition, Dortmund

    lead OTHER

Principal Investigators

  • Mathilde Kersting, Professor · Research Institute of Child Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
8 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487889 on ClinicalTrials.gov